SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001933414-24-000006
Filing Date
2024-02-08
Accepted
2024-02-08 16:41:56
Documents
18
Period of Report
2024-02-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mlys-20240207.htm   iXBRL 8-K 41990
2 EX-4.1 mlys202402078kex41.htm EX-4.1 114514
3 EX-10.1 mlys202402078kex101.htm EX-10.1 277556
4 EX-99.1 mlys202402078kex991.htm EX-99.1 9854
8 image_0.jpg GRAPHIC 5244
  Complete submission text file 0001933414-24-000006.txt   674750

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mlys-20240207.xsd EX-101.SCH 1913
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mlys-20240207_lab.xml EX-101.LAB 25850
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mlys-20240207_pre.xml EX-101.PRE 13589
19 EXTRACTED XBRL INSTANCE DOCUMENT mlys-20240207_htm.xml XML 2929
Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Filer) CIK: 0001933414 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41614 | Film No.: 24609752
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)